1. Sawamura D, Nakano H, Matsuzaki Y. Overview of epidermolysis bullosa. J Dermatol. 2010; 37:214–219.
Article
2. Murat-Sušić S, Husar K, Skerlev M, Marinović B, Babić I. Inherited epidermolysis bullosa - the spectrum of complications. Acta Dermatovenerol Croat. 2011; 19:255–263.
3. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009; 61:367–384.
Article
4. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008; 58:931–950.
Article
5. Gonzalez ME. Evaluation and treatment of the newborn with epidermolysis bullosa. Semin Perinatol. 2013; 37:32–39.
Article
6. Kho YC, Rhodes LM, Robertson SJ, Su J, Varigos G, Robertson I, et al. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol. 2010; 146:635–640.
7. Rho YJ, Choi YA, Lee KS, Song JY. Epidemiologic study of epidermolysis bullosa in Korea. Korean J Dermatol. 1993; 31:931–936.
8. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol. 2009; 61:387–402.
Article
9. Fewtrell MS, Allgrove J, Gordon I, Brain C, Atherton D, Harper J, et al. Bone mineralization in children with epidermolysis bullosa. Br J Dermatol. 2006; 154:959–962.
Article
10. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr. 2008; 51:1–25.
Article
11. Wilcox WD, Nieburg P, Miller DS, et al. Failure to thrive. A continuing problem of definition. Clin Pediatr (Phila). 1989; 28:391–394.
12. Boeira VL, Souza ES, Rocha Bde O, Oliveira PD, de Oliveira Mde F, Rêgo VR, et al. Inherited epidermolysis bullosa: clinical and therapeutic aspects. An Bras Dermatol. 2013; 88:185–198.
Article
13. Fine JD. Inherited epidermolysis bullosa: recent basic and clinical advances. Curr Opin Pediatr. 2010; 22:453–458.
Article
14. Fine JD. Epidermolysis bullosa. Clinical aspects, pathology, and recent advances in research. Int J Dermatol. 1986; 25:143–157.
15. Fine JD, Johnson LB, Weiner M, Suchindran C. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr. 2008; 152:276–280.
Article
16. Yuen WY, Lemmink HH, van Dijk-Bos KK, Sinke RJ, Jonkman MF. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands. Br J Dermatol. 2011; 165:1314–1322.
Article
17. Yuen WY, Duipmans JC, Molenbuur B, Herpertz I, Mandema JM, Jonkman MF. Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa. Br J Dermatol. 2012; 167:374–382.
Article
18. Spencer NJ. Failure to think about failure to thrive. Arch Dis Child. 2007; 92:95–96.
Article
19. Jaffe AC. Failure to thrive: current clinical concepts. Pediatr Rev. 2011; 32:100–107.
Article
20. Martinez AE, Mellerio JE. Osteopenia and osteoporosis in epidermolysis bullosa. Dermatol Clin. 2010; 28:353–355.
Article
21. Haynes L. Nutrition for children with epidermolysis bullosa. Dermatol Clin. 2010; 28:289–301.
Article
22. Fine JD, Johnson LB, Weiner M, Stein A, Cash S, Deleoz J, et al. Pseudosyndactyly and musculoskeletal contractures in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry, 1986-2002. J Hand Surg Br. 2005; 30:14–22.
Article
23. Fine JD, Johnson LB, Weiner M, Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J Pediatr Gastroenterol Nutr. 2008; 46:147–158.
Article